TGFB1 and neoplasm: In normal and premalignant epithelial cells, TGF-β signaling leads to the activation of CDK inhibitors p21 and p15, which can stop the cell cycle in the G1 phase and thus, suppress the proliferation of tumor cells [73,75,76].